Alphatec vs AtriCure
ATEC and ATRC side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ATEC and ATRC compare
AtriCure is the larger company, worth 2.6 times as much as Alphatec ($2.8B against $1.1B).
Alphatec grew revenue faster over the last twelve months (15.3% versus 13.8% for AtriCure).
AtriCure keeps more of each dollar of sales as profit, with a net margin of 2.5% compared with −10.3% at Alphatec.
AtriCure scores higher on the StockData Score (12 against 7 for Alphatec), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ATEC | ATRC |
|---|---|---|
| Size and price | ||
| Market cap | $1.1B | $2.8B |
| Share price | $7.06 | $55.98 |
| Change, 1 year | −65.9% | 70.4% |
| Change, 5 years | −37.4% | −27.9% |
| Beta (5Y) | 1.15 | 1.25 |
| Employees | 913 | 1,350 |
| StockData Score | ||
| Total score | 7 | 12 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 3 | 4 (better) |
| Performance score | 2 | 3 (better) |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 187× |
| P/S | 1.3× (better) | 4.8× |
| P/B | – | 5.3× |
| EV/EBITDA | 40.0× (better) | 160× |
| P/FCF | 357× | 53.8× (better) |
| FCF yield | 0.28% | 1.9% (better) |
| Fair value | – | $8.03 |
| Margin of safety | – | −597% |
| Growth | ||
| Revenue growth (TTM) | 15.3% (better) | 13.8% |
| Revenue growth, 5Y average | 39.5% (better) | 20.9% |
| Profitability | ||
| Gross margin | 71.3% | 76.7% (better) |
| Operating margin | −3.6% | 2.9% (better) |
| Net margin | −10.3% | 2.5% (better) |
| FCF margin | 0.37% | 9.0% (better) |
| Return on equity | −1888% | 2.9% (better) |
| Return on invested capital | −5.0% | 3.9% (better) |
| Financial health | ||
| Debt / equity | – | 0.11 |
| Net debt / EBITDA | 12.06 (better) | −7.40 |
| Interest coverage | −0.7× | 2.9× (better) |
| Current ratio | 2.36 | 4.33 (better) |
| Altman Z-score | −0.49 | 9.86 (better) |
| Piotroski F-score | 6 | 7 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 72.7% | 104% |
| Held by insiders | 23.5% | 4.0% |
| Insider net buying, 12 months | −$40.9M | −$4.4M (better) |
| Short interest, % of float | 12.0% | 10.0% |
Go deeper
- ATEC stock overview
- ATEC income statement
- ATEC valuation and score
- ATRC stock overview
- ATRC income statement
- ATRC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.